HUP0003500A3 - Cyclopeptide derivatives as adhesion inhibitors, pharmaceutical composition containing thereof, process for production thereof and their use - Google Patents
Cyclopeptide derivatives as adhesion inhibitors, pharmaceutical composition containing thereof, process for production thereof and their useInfo
- Publication number
- HUP0003500A3 HUP0003500A3 HU0003500A HUP0003500A HUP0003500A3 HU P0003500 A3 HUP0003500 A3 HU P0003500A3 HU 0003500 A HU0003500 A HU 0003500A HU P0003500 A HUP0003500 A HU P0003500A HU P0003500 A3 HUP0003500 A3 HU P0003500A3
- Authority
- HU
- Hungary
- Prior art keywords
- production
- pharmaceutical composition
- composition containing
- adhesion inhibitors
- cyclopeptide derivatives
- Prior art date
Links
- 102000001189 Cyclic Peptides Human genes 0.000 title 1
- 108010069514 Cyclic Peptides Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19736772A DE19736772A1 (de) | 1997-08-23 | 1997-08-23 | Cyclopeptidderivate |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0003500A2 HUP0003500A2 (hu) | 2001-02-28 |
HUP0003500A3 true HUP0003500A3 (en) | 2001-12-28 |
Family
ID=7839977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0003500A HUP0003500A3 (en) | 1997-08-23 | 1998-08-14 | Cyclopeptide derivatives as adhesion inhibitors, pharmaceutical composition containing thereof, process for production thereof and their use |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1007545A2 (hu) |
JP (1) | JP2001514186A (hu) |
KR (1) | KR20010022828A (hu) |
CN (1) | CN1267306A (hu) |
AR (1) | AR013650A1 (hu) |
AU (1) | AU734829B2 (hu) |
BR (1) | BR9811992A (hu) |
CA (1) | CA2301182A1 (hu) |
DE (1) | DE19736772A1 (hu) |
HU (1) | HUP0003500A3 (hu) |
ID (1) | ID23952A (hu) |
NO (1) | NO20000860D0 (hu) |
PL (1) | PL341090A1 (hu) |
RU (1) | RU2200166C2 (hu) |
SK (1) | SK2132000A3 (hu) |
TW (1) | TW477793B (hu) |
WO (1) | WO1999010371A2 (hu) |
ZA (1) | ZA987558B (hu) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA43823C2 (uk) * | 1992-07-06 | 2002-01-15 | Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН |
DE4310643A1 (de) * | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
DE4415310A1 (de) * | 1994-04-30 | 1995-11-02 | Merck Patent Gmbh | Cyclopeptide |
JPH07316193A (ja) * | 1994-05-24 | 1995-12-05 | Asahi Glass Co Ltd | ペプチド誘導体およびその用途 |
-
1997
- 1997-08-23 DE DE19736772A patent/DE19736772A1/de not_active Withdrawn
-
1998
- 1998-08-14 AU AU95319/98A patent/AU734829B2/en not_active Ceased
- 1998-08-14 CN CN98808380A patent/CN1267306A/zh active Pending
- 1998-08-14 PL PL98341090A patent/PL341090A1/xx unknown
- 1998-08-14 CA CA002301182A patent/CA2301182A1/en not_active Abandoned
- 1998-08-14 ID IDW20000532A patent/ID23952A/id unknown
- 1998-08-14 JP JP2000507697A patent/JP2001514186A/ja active Pending
- 1998-08-14 KR KR1020007001430A patent/KR20010022828A/ko not_active Application Discontinuation
- 1998-08-14 EP EP98948833A patent/EP1007545A2/de not_active Withdrawn
- 1998-08-14 HU HU0003500A patent/HUP0003500A3/hu unknown
- 1998-08-14 WO PCT/EP1998/005161 patent/WO1999010371A2/de not_active Application Discontinuation
- 1998-08-14 SK SK213-2000A patent/SK2132000A3/sk unknown
- 1998-08-14 BR BR9811992-3A patent/BR9811992A/pt not_active IP Right Cessation
- 1998-08-14 RU RU2000107122/04A patent/RU2200166C2/ru not_active IP Right Cessation
- 1998-08-19 TW TW087113657A patent/TW477793B/zh not_active IP Right Cessation
- 1998-08-20 ZA ZA987558A patent/ZA987558B/xx unknown
- 1998-08-21 AR ARP980104136A patent/AR013650A1/es not_active Application Discontinuation
-
2000
- 2000-02-22 NO NO20000860A patent/NO20000860D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO20000860L (no) | 2000-02-22 |
NO20000860D0 (no) | 2000-02-22 |
ZA987558B (en) | 1999-02-23 |
HUP0003500A2 (hu) | 2001-02-28 |
PL341090A1 (en) | 2001-03-26 |
AR013650A1 (es) | 2001-01-10 |
AU9531998A (en) | 1999-03-16 |
DE19736772A1 (de) | 1999-02-25 |
AU734829B2 (en) | 2001-06-21 |
ID23952A (id) | 2000-06-08 |
CN1267306A (zh) | 2000-09-20 |
TW477793B (en) | 2002-03-01 |
BR9811992A (pt) | 2000-09-05 |
CA2301182A1 (en) | 1999-03-04 |
WO1999010371A2 (de) | 1999-03-04 |
RU2200166C2 (ru) | 2003-03-10 |
JP2001514186A (ja) | 2001-09-11 |
KR20010022828A (ko) | 2001-03-26 |
WO1999010371A3 (de) | 1999-05-27 |
EP1007545A2 (de) | 2000-06-14 |
SK2132000A3 (en) | 2000-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0200396A3 (en) | Gluckokinase activators, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0203548A3 (en) | New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0204245A3 (en) | Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0203669A3 (en) | Renin inhibitors, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
HUP0300618A3 (en) | Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0203122A3 (en) | Fab i inhibitors, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
HUP9801045A3 (en) | Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation | |
HUP9801044A3 (en) | Sulfonylamino-carboxylic acid derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0000941A3 (en) | Sulfamide derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
HUP0101281A3 (en) | Diphenyl-piperidine butanamides as glycine transport inhibitors, process for producing them, use of them for producing medicaments and the pharmaceutical compositions containing them | |
HUP9900728A3 (en) | Peptide derivatives as thrombin inhibitors, process for producing them and pharmaceutical compositions containing them | |
HU9802653D0 (en) | Substituted imidazolidine derivatives, process for producing them, their use, and pharmaceutical compositions containing them | |
HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
HUP0002404A3 (en) | Amino acid derivatives, pharmaceutical compositions comprising thereof, process for preparation them and their use | |
HUP0202075A3 (en) | Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP9800781A3 (en) | Propanolamine derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
HUP0002300A3 (en) | Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
HUP0002952A3 (en) | Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them | |
HUP9900071A3 (en) | Tribenzimidazoles useful as topoisomerase i inhibitors, pharmaceutical compositions containing them and their use | |
GB9617893D0 (en) | New pharmaceutical derivatives, process for obtaining them and pharmaceutical compositions containing them | |
HUP9901485A2 (en) | Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use | |
AU2841199A (en) | Novel bis-benzamide derivatives, method for making same pharmaceutical compositions containing them and use thereof as medicine | |
HUP0201315A3 (en) | 4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them |